IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
Clinical trial NCT04033276 · COMPLETED
Trial details
- NCT number
- NCT04033276
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-08
- Primary completion
- 2021-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.